EG
Eithan Galun
Principal Investigator
Hadassah Medical Center
I'm working on
10 months ago
Immunology, Liver Disease, Molecular Medicine, Cancer Biology
About
Research focuses on cytokine signaling, immune-microbiome crosstalk, and gene regulation driving liver disease and cancer. Combines models and patient cohorts to identify circulating biomarkers, enable noninvasive diagnostics, and inform therapies, including interventional oncology.
OS-090 A cfChIP-seq liquid biopsy for the diagnosis of acute cellular rejection following liver transplantation
Journal of Hepatology
•2025
FRI-312 A cfChIP-seq liquid biopsy for the diagnosis of autoimmune hepatitis
Journal of Hepatology
•2025
886: HISTONE-BASED LIQUID BIOPSY FOR THE DIAGNOSIS OF ACUTE CELLULAR REJECTION FOLLOWING LIVER TRANSPLANTATION
Gastroenterology
•2025
WED-534 MiR122 expression regulates liver immune tolerance and microenvironment
Journal of Hepatology
•2024
[GENE THERAPY: FROM TECHNOLOGY TO REALITY].
PubMed
•2024
Fibroblast growth factors induce hepatic tumorigenesis post radiofrequency ablation
Scientific Reports
•2023
Radiofrequency Ablation–Induced Tumor Growth Is Suppressed by MicroRNA-21 Inhibition in Murine Models of Intrahepatic Colorectal Carcinoma
Journal of Vascular and Interventional Radiology
•2023
Identification of hepatocyte immune response in Autoimmune Hepatitis from human plasma cfChIP-seq
bioRxiv (Cold Spring Harbor Laboratory)
•2023
Ductular reaction is mediated by CD24 and regulated by miR-122
Journal of Hepatology
•2023
Forthcoming Articles
Journal of Vascular and Interventional Radiology
•2023
No funding yet
This innovator hasn't added funding yet. In the meantime, you might want to explore their publications, patents, and other profile details.
No patents yet
This innovator hasn't added patents yet. In the meantime, you might want to explore their publications, funding, and other profile details.
Partner smarter. Move faster.
Get new partnering requests
delivered to your inbox.
delivered to your inbox.
© 2026 Halo Cures, Inc.